近五年已发表的代表性论著 |
Xiangjing Meng,Guangying Du*, Liang Ye, Shanyue Sun, Qiaofeng Liu, Hongbo Wang, Wenyan Wang, Zimei Wu, Jingwei Tian*.Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model. International Journal of Immunopathology and Pharmacology,2017,30(3):215-226. Guangying Du, Liang Ye, Guoying Zhang, et al. Human IL18-IL2 fusion protein as a potential antitumor reagent by enhancing NK cell cytotoxicity and IFN-γ production. Journal of Cancer Research and Clinical Oncology, 2012,138(10):1727-1736. Guangying Du, Haibo Zhu, Pengfei Yu, et al. SMND-309 promotes angiogenesis in human umbilical vein endothelial cells through activating erythropoietin receptor/STAT3/VEGF pathways. European Journal of Pharmacology. 2013,700(1-3):173-180. Jingwei Tian, Wenyan Wang, Liang Ye,Guangying Du, et al. A 12-week intramuscular toxicity study of risperidone-loaded microspheres in Beagle dogs. Human and Experimental Toxicology, 2013,1–15. (Corresponding author) Jingwei Tian,Guangying Du, Liang Ye, et al.Three-month subchronic intramuscular toxicity study of rotigotine-loaded microspheres in Cynomolgus monkeys. Food and Chemical Toxicology. 2013 52:143-152. Liang Ye, Zhiping Hu,Guangying Du, et al. Antidepressant-like effects of the extract from Cimicifuga foetida L. Journal of Ethnopharmacology, 2012, 144(3):683-691. Huayang Zheng,Guangying Du, Ruihua Zhao, et al (the first two authors contributed equally to this work). Enhanced allogeneic skin-graft survival using sCD95L, sCD152,interleukin-10 and transforming growth factor-βin combination,and comparison with ciclosporin. Clinical and Experimental Dermatology, 2009, 34(6):721-727 |
